These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23658067)

  • 1. Studies on pharmacokinetic mechanism of phenytoin resistance in refractory epilepsy.
    Lai ML; Tien YE; Huang YS; Huang JD
    J Pharm Sci; 2013 Sep; 102(9):3189-95. PubMed ID: 23658067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
    Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
    Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.
    Kurata Y; Ieiri I; Kimura M; Morita T; Irie S; Urae A; Ohdo S; Ohtani H; Sawada Y; Higuchi S; Otsubo K
    Clin Pharmacol Ther; 2002 Aug; 72(2):209-19. PubMed ID: 12189368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
    Lakhan R; Misra UK; Kalita J; Pradhan S; Gogtay NJ; Singh MK; Mittal B
    Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR; Kulkarni NB; Gandhe PP; Thelma BK; Ravat SH; Gogtay NJ; Thatte UM
    J Postgrad Med; 2014; 60(3):265-9. PubMed ID: 25121365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of P-glycoprotein on clopidogrel absorption.
    Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
    Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats.
    Neerati P; Ganji D; Bedada SK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):27-31. PubMed ID: 21640186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy.
    Lovrić M; Božina N; Hajnšek S; Kuzman MR; Sporiš D; Lalić Z; Božina T; Granić P
    Ther Drug Monit; 2012 Oct; 34(5):518-25. PubMed ID: 22972536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A; Dorado P; Fricke-Galindo I; Jung-Cook H; Monroy-Jaramillo N; Martínez-Juárez IE; Familiar-López I; Peñas-Lledó E; LLerena A; López-López M
    Pharmacogenomics J; 2016 Jun; 16(3):286-92. PubMed ID: 26122019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers.
    Kim KA; Joo HJ; Lee HM; Park JY
    Pharmacogenet Genomics; 2014 Jan; 24(1):35-42. PubMed ID: 24240480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.
    Marchi N; Guiso G; Rizzi M; Pirker S; Novak K; Czech T; Baumgartner C; Janigro D; Caccia S; Vezzani A
    Epilepsia; 2005 Oct; 46(10):1613-9. PubMed ID: 16190932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
    Johne A; Köpke K; Gerloff T; Mai I; Rietbrock S; Meisel C; Hoffmeyer S; Kerb R; Fromm MF; Brinkmann U; Eichelbaum M; Brockmöller J; Cascorbi I; Roots I
    Clin Pharmacol Ther; 2002 Nov; 72(5):584-94. PubMed ID: 12426522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
    Uchida Y; Ohtsuki S; Terasaki T
    Drug Metab Dispos; 2014 Oct; 42(10):1719-26. PubMed ID: 25061162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.
    Lazarowski A; Czornyj L
    Drug Metabol Drug Interact; 2011; 26(1):21-6. PubMed ID: 21557674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs.
    Hung CC; Chen CC; Lin CJ; Liou HH
    Pharmacogenet Genomics; 2008 May; 18(5):390-402. PubMed ID: 18408562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses.
    Hung CC; Jen Tai J; Kao PJ; Lin MS; Liou HH
    Pharmacogenomics; 2007 Sep; 8(9):1151-8. PubMed ID: 17924830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.